Original Source(s)
Related Content
Precision Treatment, Earlier Molecular Detection and De-escalation Transforming Breast Cancer Care
Breast cancer management is becoming increasingly biology-driven, with treatment decisions extending well beyond anatomic stage and conventional receptor classification.
2026 ASCO Breast Cancer Highlights: SENOMAC
Harold Burstein, MD, PhD, and Laura S. Dominici, MD, FACS, discuss highlights from the SENOMAC trial which sheds light on whether some patients with early breast cancer and limited lymph node involvement can safely avoid additional axillary surgery.
October 15, 2026
-
1 min